APS-I patients harbored autoantibodies against IFN-α, IL-17A, IL-17F, and IL-22.

APS-I patients harbored autoantibodies against IFN-α, IL-17A, IL-17F, and IL-22.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal